Navigation Links
3D Biomatrix Announces Stipend to Present at Spring 2013 Conferences

Ann Arbor, MI (PRWEB) March 19, 2013

3D Biomatrix, a leader in three-dimensional (3D) cell culture products, is pleased to announce the winners of its Spring 2013 Conference Stipend. The three researchers were each awarded $500 for presenting the results they obtained from using Perfecta3D® Hanging Drop Plates at Spring 2013 conferences. The winners are:

(1) Wei-Sheng Chen, Tufts University, TD139, a galectin-1 and galectin-3- specific inhibitor, mitigates VEGF-A-induced Angiogenesis (Experimental Biology 2013, April 20-24, Boston, MA)
(2) Marylou Ingram, Huntington Medical Research Center, Tumor Histoids: Scalable Production of Living Human Mini-tumors for High Throughput Drug Screening (Cyto2013, May 19-22, San Diego, CA)
(3) Xuemei Zhong, Boston University Medical Center, Guardian Angels in the Graveyard: B1 B Cells Promote Thymic Treg Survival (Immunology 2013 AAI Annual Meeting, May 3-7, Honolulu, HI)

Additional information about the presentations, including abstracts and presentation dates, times, and locations, can be found on the 3D Biomatrix website.

Perfecta3D Hanging Drop Plates allow life science researchers to work in an environment that simulates the three dimensions of the human body more closely than existing flat, two-dimensional (2D) cell culture techniques, such as the Petri dish. With one spheroid per well, the plates facilitate the formation, culture, and testing of 3D spheroids and stem cell aggregates, including embryoid bodies, in a standard 96- or 384-well plate format without the aid of coatings or matrices. They are easy to use, and cell growth can be monitored regularly. Media and compounds can be added or removed from the top of the plate without requiring new equipment, and cells can be added for co-cultures.

“Our 3D plates continue to be successfully used for work in cancer models, vascularization research, and immunology,” stated 3D Biomatrix CEO Laura Schrader. “We are proud to support these researchers by helping them present their exciting new data in these important research areas.”

More information about the conference stipend and the Perfecta3D Hanging Drop Plates can be found at

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. EAS Consulting Group, Experts in Quality Regulatory Services Related to FDA Issues, Announces Upcoming Dietary Supplement Seminars in Salt Lake City
2. Probiotic Action Announces China’s $5 Billion Dollar Investment in Probiotics
3. DuPont Tate & Lyle Bio Products Announces Novel Application for Zemea® Propanediol
4. EAG Announces New General Manager of Release-To-Production (RTP) Division
5. Neuralstem Announces 2012 Financial Results, Provides Clinical Trials Update
6. Senomyx Announces Fourth Quarter And Full Year 2012 Financial Results And Initiation Of New Direct Sales Strategy
7. Verenium Announces Preliminary Financial Results For Fiscal 2012
8. Probiotic Action Announces Probiotics Lead the Digestive Health Market
9. Annual Conference about Technology Solutions for People with Disabilities Announces Program
10. DistinctBright, Probiotic Cleaner, Announces their Probiotic Cleaner is Safe for Pets
11. Research and Markets Announces the Release of Transdermal Pain Management to 2016. Products, Markets, Forecasts and Opportunities
Post Your Comments:
(Date:6/27/2016)... , ... June 27, 2016 , ... ... bring innovative medical technologies, services and solutions to the healthcare market. The company's ... of various distribution, manufacturing, sales and marketing strategies that are necessary to help ...
(Date:6/24/2016)... Epic Sciences unveiled a liquid biopsy ... PARP inhibitors by targeting homologous recombination deficiency (HRD) ... test has already been incorporated into numerous clinical ... Over 230 clinical trials are investigating ... PARP, ATM, ATR, DNA-PK and WEE-1. Drugs targeting ...
(Date:6/23/2016)... June 23, 2016   Boston Biomedical , ... compounds designed to target cancer stemness pathways, announced ... granted Orphan Drug Designation from the U.S. Food ... gastric cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin ... to inhibit cancer stemness pathways by targeting STAT3, ...
(Date:6/23/2016)... 23, 2016  The Prostate Cancer Foundation (PCF) is pleased to ... faster cures for prostate cancer. Members of the Class of 2016 were selected ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
Breaking Biology Technology:
(Date:6/7/2016)... 2016  Syngrafii Inc. and San Antonio Credit ... includes integrating Syngrafii,s patented LongPen™ eSignature "Wet" solution ... will result in greater convenience for SACU members ... maintaining existing document workflow and compliance requirements. ... Highlights: ...
(Date:6/2/2016)...   The Weather Company , an IBM Business (NYSE: ... capability in which consumers will be able to interact with ... via voice or text and receive relevant information about the ... Marketers have long sought an advertising solution that can create ... relevant and valuable; and can scale across millions of interactions ...
(Date:5/24/2016)... , May 24, 2016 Ampronix facilitates superior patient care by providing ...  3D medical LCD display is the latest premium product recently added to the range ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
Breaking Biology News(10 mins):